To give an indication of being a colour blind fan, I struggle to distinguish the Netherlands kit from the grass so have to rely on heads and boots

Attacking the weather channel is a good indication that the White House, much like Moscow or Beijing, has created a world where telling the truth is a liability. A leadership structure like that is the only way a nation like ours loses a war to Iran. And here we are

Feels like they will announce the hilo live details next wednesday 🤔 although I've decided to give it up because no SWORD if naoto's response is any indication but then again he is involved next week omg? chotto matte

Why Humacyte is a Strong Buy at the $1 Mark: The Ultimate Inflection Point At its current price of around $1.00, Humacyte ($HUMA) presents a highly asymmetric risk-to-reward profile. The market has temporarily penalized the stock for a recent dilution, completely masking a massive fundamental shift that dramatically increases the company's odds of long-term success. Here is the breakdown of why $HUMA is sitting at a major cyclical inflection point. 1. The Clinical Breakthrough & The Dilution Trap Humacyte recently released stellar final results from its Phase 3 hemodialysis trial, significantly de-risking the path toward FDA approval. Unfortunately, management did what biotech companies routinely must do: they immediately used that positive momentum to shore up the balance sheet, initiating a $50 million public offering. While the market hates short-term dilution, this capital injection was a strategic necessity: The Cash Position: Humacyte will sit on approximately $75 million in cash. The Baseline Burn: With a quarterly operational cash burn of roughly $25 million, this current cash pile safely funds the company through the end of Q1 2027. 2. The $60 Million Capital Bridge As we approach the anticipated FDA decision, the market should begin pricing in an approval, driving the equity higher. This creates a highly elegant funding backstop already built into the share structure: The $2.11 Warrant Trigger: If the stock clears and holds above $2.11, the company can trigger the exercise of outstanding warrants, injecting an additional $60 million of non-debt capital directly onto the balance sheet. This $60 million influx provides the perfect financial bridge to carry Humacyte all the way through to the Symvess commercial approval, which is expected sometime in Q2 or Q3 of 2027. 3. The Commercial Game-Changer: Dialysis vs. Trauma Many investors are looking at Humacyte solely through the lens of its vascular trauma indication. However, trauma is notoriously difficult to commercialize; you have to spend immense resources persuading individual hospital networks and emergency surgeons to change their acute care protocols. Symvess for hemodialysis is an entirely different beast: Immediate Market Access: The market size for dialysis access is exponentially larger than trauma. The Fresenius Catalyst: Humacyte has a powerful strategic partner in Fresenius Medical Care, the global leader in dialysis care. This partnership provides an established, ready-made distribution network. If the real-world commercial roll-out mirrors the exceptional data seen in the clinical trials, I am highly confident Humacyte can eventually capture 30% to 40% of the total market share. Achieving this level of penetration will effectively shut the door on future dilutive capital raises. 4. The Domino Effect: A Multi-Billion Dollar Pipeline The brilliance of Humacyte's platform is that the Acellular Tissue Engineered Vessel (ATEV) used for trauma, dialysis, and Peripheral Arterial Disease (PAD) is exactly the same product. An approval in dialysis establishes a powerful domino effect: [Dialysis Approval] ➔ [Validates Platform] ➔ [De-risks PAD Approval] ➔ [De-risks CABG Approval] The Margin Expansion: Because it is the exact same underlying technology, manufacturing costs will plummet as production scales up, significantly boosting gross margins. The Familiarity Advantage: Once hospitals, vascular surgeons, and insurance providers become comfortable with Symvess for dialysis, adoption friction for the PAD and CABG (coronary artery bypass graft) indications will vanish, leading to much faster revenue generation. The Revenue Potential: Dialysis, PAD, and CABG each represent distinct commercial opportunities with peak sales potential ranging from $500 million to over $1.5 billion each. The Long-Term Valuation Target We are looking at a classic biotech inflection point. The short-term dilution pain is behind us, the cash runway is clear, and the commercial runway is immense. If Humacyte successfully executes its launch and achieves regulatory approvals across its broader pipeline indications, a long-term realistic stock price target of $45 to $100 per share is completely achievable. Disclaimer: This is my own fundamental and financial opinion. Not Financial Advice (NFA). Do your own research. Enjoyed this deep dive? Hit follow for future $HUMA updates, where I’ll continue breaking down the core fundamentals and mapping out the technical charts!

If personal experience is any indication it's a cascade effect from small things onto larger things

When all machinery fail, Armed forces are called in. Involvement of Army is a clear indication that civic bodies failed to do what they were supposed to do it. 2 Offr, 5 JCO and more than 100 soldiers are deployed for cleaning job rather than fighting or getting trained to fight

For maximum 3 minutes and no foreplay? Making no sexual noises? Without triggering the tracking software? How are they positioned? Is he in her lap? Or is he behind her? Either way his face must be out of frame the entire time. Either way they both got into position in perfect silence, had sex with no indication from her other than a 30 second clip. And she did all of this while paying perfect attention to the story and reacting appropriately before, during and after to the story's events. A clip which, as a reminder, is explained by her saying 30 seconds earlier, "Am I reading e-sex?" and making fun of the writing.

First indication of confirmation that @dc_mma was threatened to take down the screen shot Retribution already started

This is how much they have gotten in the last 45 years. Well over 120 trillion. In cash. Bernie has been there most of the time. Over 40 T since @SenWarren got there. Getting them part of another trillion will solve nothing, I mean, if past performance is any indication … ;-)

Dear @elonmusk, I like what you’re doing a lot and I want to share in your vision for Mars. (I missed the IPO because of not seeing an email from the brokerage 17 hours before market open last Friday to confirm my indication of interest which was indicated over a week prior.) I actually interviewed once or twice for SpaceX in Redmond when I lived in Seattle, but I didn’t get the job. I’m an actor in Atlanta now and do sales and marketing for a company back in Washington. Have you ever played #kerbalspaceprogram ? I built a lunar Mun base with a rover and launched it in seven ish stages, assembling them all in orbit. I think it’s pretty cool. I’m not much of a mathematician or physicist, but sometimes I do math on paper. I understand the concepts, but I am more of a philosophical thinker and person of faith! I am a pioneer in my own life and believe in the pursuit of truth. My friend @ThatMossman wants to go to space too. Anyway, you probably won’t see this, but worth a Munshot! Regardless, I’ll pray for your ventures Starman. P.S. My sister thinks you’re greedy because you are a trillionaire on paper. Lol. I love her no less.

#NCE1 Alert | #Lynavoy (#Linerixibat) Indication: Cholestatic Pruritus associated with Primary Biliary Cholangitis Explore: ncegrid.springbiosolution.co… #NCEGrid #ParaIV #FirstToFile #aBLA #SpringBioSolution #Pharma

"Fine-tuning is evident in the precise values of constants like gravity." False again. Just because a value is so is no indication it could be otherwise. Last part follows:

Yes copyright strike of the bat is wild contact the creator first to try and resolve it behind the scenes first and their is no indication Nick tried that

people saying the sexual assault in obsession isn’t assault when we get the dinner scene as indication that bear realizes nikki is with him because of the wish and it immediately hard cuts to him and her together in bed with her face in pain… very revealing